TP53 and cancer: In contrast, several studies indicate that miR-192 acts as a tumor suppressor as it inhibits cancer cell proliferation through induction of p53-dependent cell cycle arrest at both the G1 and G2 phases in colon cancer [133] and through targeting Rb1 in lung cancer [40].